Early Discrimination between Transient and Permanent Congenital Hypothyroidism in Children with Eutopic Gland

Area of Science:

• Pediatric Endocrinology
• Neonatal Screening
• Thyroid Disorders

Background:

• Congenital hypothyroidism (CH) requires timely diagnosis and management.
• Distinguishing between permanent (P-CH) and transient (T-CH) forms early is crucial for appropriate treatment duration.
• Accurate differentiation impacts long-term patient outcomes and healthcare resource allocation.

Purpose of the Study:

• To identify clinical, biochemical, and imaging factors enabling early differentiation between permanent and transient congenital hypothyroidism.
• To establish criteria for distinguishing P-CH from T-CH in infants with eutopic thyroid glands.

Main Methods:

• Retrospective analysis of clinical, biochemical, and imaging data from 64 children diagnosed with CH between 1998 and 2011.
• Evaluation of levothyroxine (L-T4) dosage requirements per kilogram of body weight over a 3-year treatment period.
• Comparison of L-T4 dose adjustments needed to maintain normal thyroid-stimulating hormone (TSH) levels between P-CH and T-CH groups.

Main Results:

• Children with T-CH required significantly lower mean L-T4 doses compared to those with P-CH.
• No patients with T-CH needed dose increments to maintain normal TSH levels, unlike 16/18 children with P-CH.
• Specific L-T4 dosage thresholds at 12 and 24 months were identified as highly suggestive of either P-CH or T-CH.

Conclusions:

• Levothyroxine requirements exceeding 4.9 µg/kg/day at 12 months or 4.27 µg/kg/day at 24 months strongly suggest permanent CH.
• Levothyroxine requirements below 1.7 µg/kg/day at 12 months or 1.45 µg/kg/day at 24 months are highly indicative of transient CH in infants with eutopic glands.
• Monitoring L-T4 requirements in the initial years of treatment facilitates early and accurate discrimination between transient and permanent CH in cases with eutopic glands.